✦ LIBER ✦

Timing of Glycoprotein IIb/IIIa Inhibitor Use and Outcomes Among Patients With Non–ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention (Results from CRUSADE)

✍ Scribed by Pierluigi Tricoci; Eric D. Peterson; Anita Y. Chen; L. Kristin Newby; Robert A. Harrington; Adam B. Greenbaum; Chistopher P. Cannon; C. Michael Gibson; James W. Hoekstra; Charles V. Pollack Jr.; E. Magnus Ohman; W. Brian Gibler; Matthew T. Roe

Book ID: 113443768
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 164 KB
Volume: 99
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2006.12.066

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective evaluation of glycoprotein I

Prospective evaluation of glycoprotein IIb/IIIa inhibition with eptifibatide in patients undergoing percutaneous coronary intervention for ST-segment elevation myocardial infarction

✍ P Lachance; J.-P. Déry; S Grenier; G Barbeau; B Noël; É Larose; J Rodés-Cabau; O 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Use of platelet glycoprotein IIb/IIIa in

Use of platelet glycoprotein IIb/IIIa inhibitors in patients with unstable angina and non-ST-segment elevation myocardial infarction

✍ Eddy S. Lang; Marc Afilalo 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 44 KB

AS-9: Thrombus Aspiration in Primary Per

AS-9: Thrombus Aspiration in Primary Percutaneous Coronary Intervention Improves Early Myocardial Reperfusion in Patients with ST-Segment Elevation Myocardial Infarction without Upstream Use of Glycoprotein IIb/IIIa Inhibitors

✍ Jeong Hoon Kim; Byung Ok Kim; Kwang-Sil Kim; Choong-Won Goh; Young-Sup Byun; Sun 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 112 KB

TCT-313: A randomized Controlled Trial o

TCT-313: A randomized Controlled Trial of Upstream versus Bail-out Use of Glycoprotein IIb/IIIa Inhibitor Combined with Selective Use of Aspiration Thrombectomy during Primary Percutaneous Coronary Intervention in Patients with ST-segment Elevation Myocardial Infarction

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Efficacy and safety of enoxaparin compar

Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial

✍ Harvey D. White; Neal S. Kleiman; Kenneth W. Mahaffey; Yuliya Lokhnygina; Karen 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 333 KB

Optimizing the pharmacoinvasive approach

Optimizing the pharmacoinvasive approach to acute ST-segment elevation myocardial infarction: use of half-dose thrombolytic therapy in combination with glycoprotein IIb/IIIa receptor inhibitors compared with full-dose thrombolytic therapy in the setting of routine urgent post-thrombolytic percutaneous coronary intervention

✍ Pantila Vanichakarn; Rayson C. Yang; Sheila M. Conley; Tamara A. Anderson; James 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 159 KB